Login / Signup

Reliable assessment of telomere maintenance mechanisms in neuroblastoma.

Alina MeeserChristoph BartenhagenLisa WerrAnna-Maria HellmannYvonne KahlertNadine HemstedtPeter NürnbergJanine AltmüllerSandra AckermannBarbara HeroThorsten SimonMartin PeiferMatthias FischerCarolina Rosswog
Published in: Cell & bioscience (2022)
We here propose a workflow to reliably detect TMM in neuroblastoma. We show that unambiguous classification is feasible following a stepwise approach that determines both, activation of telomerase and ALT. The workflow proposed in this study can be used in clinical routine and provides a framework to systematically and reliably determine telomere maintenance mechanisms for risk stratification and treatment allocation of neuroblastoma patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • machine learning
  • replacement therapy
  • clinical evaluation